Search form

Home
LoginSubscribe
  • Home
  • Country Intelligence
  • Industry Directory
  • Offsets / IC
  • Tenders
    • Haiti(0/week)
    • Guyana(0/week)
    • Honduras(0/week)
    • Jamaica(0/week)
    • Netherlands Antilles(0/week)
    • View all (0/week)
  • News
    • United States(1291/week)
    • Manufacturing(576/week)
    • Energy(392/week)
    • Technology(1125/week)
    • Other Manufacturing(401/week)
  • Events
  • About us
    • Who we are
    • Our People
    • Partners
    • Contact us
  • LinkedIn
  • Login
  • Twitter
  • Register
  • Home
  • News

National Psoriasis Foundation

Jun 11, 2018
Janssen to Showcase New Data Across Broad Rheumatology Portfolio and Immunology Pipeline at EULAR 2018
Jun 05, 2018
More than 5,000 Patients Enrolled in Corrona® Psoriasis Registry
May 15, 2018
Psoriatic Arthritis Awareness Project Films Premiere during PsA Action Month
Apr 17, 2018
National Psoriasis Foundation Elects New Leaders to Board of Directors
Mar 21, 2018
Sun Pharma Announces U.S. FDA Approval of ILUMYA(TM) (tildrakizumab-asmn) for the Treatment of Moderate-to-Severe Plaque Psoriasis
Mar 01, 2018
New Mexico Passes Step Therapy Reform Legislation
Feb 19, 2018
AAD 2018: Treatment with Lilly's Taltz® (ixekizumab) Resulted in Improvement in Impact of Genital Psoriasis on Sexual Activity
Feb 16, 2018
New TREMFYA® (guselkumab) Data Demonstrates Long-Term Skin Clearance In Patients With Moderate To Severe Plaque Psoriasis
Feb 14, 2018
Lilly to Showcase New Data for Taltz® (ixekizumab) and Other Products Across Immunology Pipeline at AAD Annual Meeting
Feb 12, 2018
Sun Pharma Announces Twelve Tildrakizumab Abstracts to be Presented at American Academy of Dermatology 2018 Annual Meeting
Dec 11, 2017
Corrona® Psoriasis Registry Expands to Canada; Enrolls First Patient
Nov 16, 2017
Global Psoriatic Arthritis Epidemiology and Patient Flow Analysis - 2017
Nov 14, 2017
National Psoriasis Foundation Launches Our Spot
Nov 08, 2017
ACR/ARHP 2017: Long-Term Use of Lilly's Taltz® (ixekizumab) Shows Efficacy Improvements in Psoriatic Arthritis for Patients with Prior Inadequate Response or Intolerance to TNF Inhibitors
Nov 07, 2017
New Phase 2 Data Show Treatment With TREMFYA® (guselkumab) Improved Psoriatic Arthritis Symptoms Through One Year
Nov 07, 2017
Novartis announces study data demonstrating Cosentyx® reduced signs and symptoms of psoriatic arthritis while inhibiting progression of joint structural damage
Oct 30, 2017
Lilly to Present New Data on Immunology Portfolio at ACR/ARHP Annual Meeting
Oct 24, 2017
Novartis collaborates with pop icon Cyndi Lauper to release new song in honor of World Psoriasis Day
Oct 23, 2017
National Psoriasis Foundation Collaborates on Treatment Comparison Research Study
Oct 16, 2017
Global Report: (Un)Happiness For Canadians With Psoriaisis Is Prevalent and Driven By Loneliness and Stress
  • ‹‹
  • Page 2
  • ››

Latest News

Aug 18, 2025

ComEd Restores Power to 80 Percent of Customers Impacted by Pair of Weekend Storms

Aug 17, 2025

Leach International Corporation Approves FDH Electronics Brand Stealth Aerospace as an Authorized Channel...

Aug 17, 2025

GVD Renovations Unveils Rocklin Kitchen & Bath Showroom for Sacramento-Area Remodels

Aug 17, 2025

Air Canada suspends plan to resume flights as union vows to continue strike

Aug 17, 2025

Air Canada cancels more flights as strike continues: statement

Aug 17, 2025

BooksRun Announces $1,000 Scholarship for Students in 2025

Aug 17, 2025

Israel says targeted Huthi energy site in Yemen

Aug 17, 2025

Iranians struggle with GPS disruption after Israel war

View all News

Agenda

30
September
PortugalTroia, Portugal
Seabed Security, 30 September - 01 October 2025, Troia, Portugal
Seabed Security | 30 September - 01 October 2025 | Troia, Portugal Defence iQ Announces Inaugural Seabed Security...
23
September
United KingdomLondon, UK
Countering Explosive Threat & Demining conference, September 23 - 24, 2025, London, UK
Countering Explosive Threat & Demining conference | September 23 - 24, 2025 | London, UK The Countering Explosive...
View All Events

SUBSCRIBE

to Epicos.com
Please register in order to have access to personalized daily information on world-wide A&D industry developments and business opportunities.
Subscribe

REGISTER

for Epicos.com Newsletter
Sign up for our free newsletters and receive twice a week news and intelligence regarding the Aerospace & Defence Industry, meticulously selected by our editorial team.
Sign Up
Home
  • SIGN UP FOR NEWSLETTER
  • NEWSLETTER ARCHIVE
  • ADVERTISE WITH US
  • CONTACT US
  • PRIVACY POLICY
  • INFORMATION SECURITY POLICY
© 2025 EPICOS
Made by Wedia